Newsfeeds - Spark Newswire

3 minute read

38 Stocks Moving In Wednesday’s Mid-Day Session

Today, 5:29 AM

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to purchase Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021.

AFI

1 minute read

Why Lexaria Bioscience Is Surging Today

By Randy Elias

Today, 5:29 AM

Lexaria Bioscience Corp. (NASDAQ: LEXX) shares are trading higher after the company announced its DehydraTECH significantly enhances delivery of colchicine in study VIRAL-A20-3.

LEXX

9 minute read

Stocks That Hit 52-Week Highs On Wednesday

By Benzinga Insights

Today, 5:29 AM

During Wednesday's morning trading, 125 companies set new 52-week highs.

ACC

2 minute read

Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Views

By Lisa Levin

Today, 5:29 AM

Following the market opening Wednesday, the Dow traded up 0.62% to 34,727.53 while the NASDAQ rose 0.40% to 14,557.04. The S&P also rose, gaining 0.52% to 4,345.65.

AMPY

1 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 5:29 AM

Gainers Chembio Diagnostics (NASDAQ: CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million. Lexaria Bioscience (NASDAQ: LEXX) sharesGainers

AFIB

1 minute read

Lexaria Stock Is Trading Higher As DehydraTECH Delivered Colchicine Can Potentially Treat COVID-19, Side Effects From mRNA Shots

By Vandana Singh

Today, 5:29 AM

Lexaria Bioscience Corp (NASDAQ: LEXX) has announced that its tolerability and pharmacokinetic study VIRAL-A20-3

LEXX

2 minute read

Lexaria Highlights VIRAL-A20-3 STudy Results Showing ‘Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side Effects’

By Bill Haddad

Today, 5:29 AM

Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side Effects KELOWNA, BC / ACCESSWIRE / July 21, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or

LEXX

5 minute read

Penny Stocks

Lexaria’s DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3

By The Newswire

Today, 5:29 AM

Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side Effects Kelowna, British Columbia – TheNewswire –…

LEXX

1 minute read

Lexaria Shares Are Trading Higher On Completion Of Antiviral Drug Molecular Characterization Study

By Vandana Singh

Today, 5:29 AM

Lexaria Bioscience Corp (NASDAQ:LEXX) has announced results from its antiviral drug molecular characterization study VIRAL-MC21-1, completed by Canada’s federally funded research…

LEXX

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 5:29 AM

ATHE